The role of ERVs as tumour antigens has long been described in mouse models, starting with a monoclonal antibody reactive with melanomas originating in C57BL/6 mice, which was found to be specific to the envelope glycoprotein of an eMLV shared by these melanomas40. This evidence concerns the gene ERVW-1 and melanoma.